|
1
|
Go AS, Mozaffarian D, Roger VL, Benjamin
EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, et al:
Heart disease and stroke statistics-2014 update: A report from the
American Heart Association. Circulation. 129:e28–e292. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Poole-Wilson P: The prevention of
cardiovascular disease worldwide: Whose task and WHO's task? Clin
Med (Lond). 5:379–384. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
McLaren JE, Michael DR, Ashlin TG and
Ramji DP: Cytokines, macrophage lipid metabolism and foam cells:
Implications for cardiovascular disease therapy. Prog Lipid Res.
50:331–347. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Doran AC, Meller N and McNamara CA: Role
of smooth muscle cells in the initiation and early progression of
atherosclerosis. Arterioscler Thromb Vasc Biol. 28:812–819. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lemmens K, Doggen K and De Keulenaer GW:
Role of neuregulin-1/ErbB signaling in cardiovascular physiology
and disease: Implications for therapy of heart failure.
Circulation. 116:954–960. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Marx SO, Totary-Jain H and Marks AR:
Vascular smooth muscle cell proliferation in restenosis. Circ
Cardiovasc Interv. 4:104–111. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rensen SS, Doevendans PA and van Eys GJ:
Regulation and characteristics of vascular smooth muscle cell
phenotypic diversity. Neth Heart J. 15:100–108. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li L, Zhang HN, Chen HZ, Gao P, Zhu LH, Li
HL, Lv X, Zhang QJ, Zhang R, Wang Z, et al: SIRT1 acts as a
modulator of neointima formation following vascular injury in mice.
Circ Res. 108:1180–1189. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nana-Sinkam SP and Croce CM: MicroRNAs as
therapeutic targets in cancer. Transl Res. 157:216–225. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dai R and Ahmed SA: MicroRNA, a new
paradigm for understanding immunoregulation, inflammation, and
autoimmune diseases. Transl Res. 157:163–179. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Santovito D, Mezzetti A and Cipollone F:
MicroRNAs and atherosclerosis: New actors for an old movie. Nutr
Metab Cardiovasc Dis. 22:937–943. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Santovito D, De Nardis V, Marcantonio P,
Mandolini C, Paganelli C, Vitale E, Buttitta F, Bucci M, Mezzetti
A, Consoli A and Cipollone F: Plasma exosome microRNA profiling
unravels a new potential modulator of adiponectin pathway in
diabetes: Effect of glycemic control. J Clin Endocrinol Metab.
99:E1681–E1685. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nazari-Jahantigh M, Wei Y and Schober A:
The role of microRNAs in arterial remodelling. Thromb Haemost.
107:611–618. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kang H and Hata A: MicroRNA regulation of
smooth muscle gene expression and phenotype. Curr Opin Hematol.
19:224–231. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ma X, Ma C and Zheng X: MicroRNA-155 in
the pathogenesis of atherosclerosis: A conflicting role? Heart Lung
Circ. 22:811–818. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Raitoharju E, Oksala N and Lehtimäki T:
MicroRNAs in the atherosclerotic plaque. Clin Chem. 59:1708–1721.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shu W, Yang H, Zhang L, Lu MM and Morrisey
EE: Characterization of a new subfamily of winged-helix/forkhead
(Fox) genes that are expressed in the lung and act as
transcriptional repressors. J Biol Chem. 276:27488–27497. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bot PT, Grundmann S, Goumans MJ, de Kleijn
D, Moll F, de Boer O, van der Wal AC, van Soest A, de Vries JP, van
Royen N, et al: Forkhead box protein P1 as a downstream target of
transforming growth factor-β induces collagen synthesis and
correlates with a more stable plaque phenotype. Atherosclerosis.
218:33–43. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mandolini C, Santovito D, Marcantonio P,
Buttitta F, Bucci M, Ucchino S, Mezzetti A and Cipollone F:
Identification of microRNAs 758 and 33b as potential modulators of
ABCA1 expression in human atherosclerotic plaques. Nutr Metab
Cardiovasc Dis. 25:202–209. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ernst O and Zor T: Linearization of the
bradford protein assay. J Vis Exp. 12:pii: 1918. 2010.
|
|
22
|
Abeyesinghe SM, Nicol CJ, Wathes CM and
Randall JM: Development of a raceway method to assess aversion of
domestic fowl to concurrent stressors. Behav Processes. 56:175–194.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dey BK, Gagan J and Dutta A: miR-206 and
−486 induce myoblast differentiation by downregulating Pax7. Mol
Cell Biol. 31:203–214. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Anderson C, Catoe H and Werner R: MIR-206
regulates connexin43 expression during skeletal muscle development.
Nucleic Acids Res. 34:5863–5871. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jalali S, Ramanathan GK, Parthasarathy PT,
Aljubran S, Galam L, Yunus A, Garcia S, Cox RR Jr, Lockey RF and
Kolliputi N: Mir-206 regulates pulmonary artery smooth muscle cell
proliferation and differentiation. PLoS One. 7:e468082012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Song G, Zhang Y and Wang L: MicroRNA-206
targets notch3, activates apoptosis, and inhibits tumor cell
migration and focus formation. J Biol Chem. 284:31921–31927. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen X, Yan Q, Li S, Zhou L, Yang H, Yang
Y, Liu X and Wan X: Expression of the tumor suppressor miR-206 is
associated with cellular proliferative inhibition and impairs
invasion in ERα-positive endometrioid adenocarcinoma. Cancer Lett.
314:41–53. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kondo N, Toyama T, Sugiura H, Fujii Y and
Yamashita H: miR-206 Expression is down-regulated in estrogen
receptor alpha-positive human breast cancer. Cancer Res.
68:5004–5008. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chatterjee A and Hage FG: Guidelines in
review: 2014 ACC/AHA guideline on perioperative cardiovascular
evaluation and management of patients undergoing noncardiac
surgery: A report of the American College of Cardiology/American
Heart Association Task Force on practice guidelines. J Nucl
Cardiol. 22:158–161. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Banham AH, Beasley N, Campo E, Fernandez
PL, Fidler C, Gatter K, Jones M, Mason DY, Prime JE, Trougouboff P,
et al: The FOXP1 winged helix transcription factor is a novel
candidate tumor suppressor gene on chromosome 3p. Cancer Res.
61:8820–8829. 2001.PubMed/NCBI
|
|
31
|
Zhang Y, Li S, Yuan L, Tian Y, Weidenfeld
J, Yang J, Liu F, Chokas AL and Morrisey EE: Foxp1 coordinates
cardiomyocyte proliferation through both cell-autonomous and
nonautonomous mechanisms. Genes Dev. 24:1746–1757. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Caruso P, MacLean MR, Khanin R, McClure J,
Soon E, Southgate M, MacDonald RA, Greig JA, Robertson KE, Masson
R, et al: Dynamic changes in lung microRNA profiles during the
development of pulmonary hypertension due to chronic hypoxia and
monocrotaline. Arterioscler Thromb Vasc Biol. 30:716–723. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bonnet S and Archer SL: Potassium channel
diversity in the pulmonary arteries and pulmonary veins:
Implications for regulation of the pulmonary vasculature in health
and during pulmonary hypertension. Pharmacol Ther. 115:56–69. 2007.
View Article : Google Scholar : PubMed/NCBI
|
